Ifosfamide, Carboplatin and Etoposide (ICE) combined with 41.8°C whole body hyperthermia in patients with refractory sarcoma

European Journal of Cancer

Volumn 32, Issue 5, 1996, Pages 888-892

  Wiedemann, G J ^a   Robins, H I ^b   Gutsche, S ^a   Mentzel, M ^a   Decken, M ^a   Katschinski, D M ^a   Eleftheriadis, S ^a   Crahe R ^a   Weiss, C ^a   Storer, B ^c   Wagner, T ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Carboplatin; Etoposide; Ifosfamide; Sarcoma; Whole body hyperthermia

Indexed keywords

CARBOPLATIN; ETOPOSIDE; IFOSFAMIDE; MESNA;

ADULT; ANEMIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; FEMALE; HEART ARRHYTHMIA; HUMAN; HYPERTHERMIA; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; MALE; NEPHROTOXICITY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SARCOMA; THROMBOCYTOPENIA;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; COMBINED MODALITY THERAPY; ETOPOSIDE; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; IFOSFAMIDE; MALE; MIDDLE AGED; PILOT PROJECTS; SARCOMA;

EID: 0030000214     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(95)00622-2     Document Type: Article

References (15)

1. Wiedemann GJ, Roszinski S, Biersack A, Weiss C, Wagner T. Local hyperthermia enhances cyclophosphamide, ifosfamide, and cis-diamminedichloroplatinum (II) cytotoxicity on human-derived breast carcinoma and sarcoma xenografts in nude mice. J Cancer Res Clin Oncol 1992, 118, 129-135.
2. Weidemann GJ, Siemens HJ, Mentzel M, et al. Effects of temperature on the therapeutic efficacy and pharmacokinetics of ifosfamide. Cancer Res 1993, 53, 4268-4272.
3. Cohen JD, Robins HI. Thermal enhancement of tetraplatin and carboplatin in human leukemia cells in vitro. Int J Hyperthermia 1990, 6, 1013-1017.
4. Tapazoglou E, Cohen J, Khatana A, Schmitt CL, Sapareto SA, Robins HI. Whole body hyperthermia and carboplatin: cytotoxicity for murine leukemia and normal marrow. Br J Cancer 1991, 64, 528-530.
5. Ohno D, Siddik ZH, Baba H, et al. Effect of carboplatin combined with whole body hyperthermia on normal tissue and tumor in rats. Cancer Res 1991, 51, 2994-3000.
6. Cohen JD, Robins HI, Javid M. Sensitization of C6 glioma to carboplatin cytotoxicity by hyperthermia and thymidine. J Neurooncol 1990, 9, 1-8.
7. d'Oleire F, Robins HI, Cohen JD, Schmitt CL, Spriggs D. Cytokine induction in humans by 41.8°C whole body hyperthermia. J Natl Cancer Inst 1993, 85, 833-834.
8. Robins HI, Cohen JD, Schmitt CL, et al. Phase I clinical trial of carboplatin and 41.8°C whole body hyperthermia in cancer patients. J Clin Oncol 1993, 11, 1787-1794.
9. Wiedemann GJ, d'Oleire F, Knop E, et al. Ifosfamide and Carboplatin combined with 41.8°C whole-body hyperthermia in patients with refractory sarcoma and malignant teratoma. Cancer Res 1994, 54, 5346-5350.
10. Woods JP, Schmitt CL, Rosenthal RC, d'Oleire F, Robins HI. Canine bone marrow as a potential thermal sancruary during the plateau phase of 41.8°C whole body hyperthermia. Int J Hyperthermia 1995, 11, 49-57.
11. Robins HI, Neville AJ, Cohen JD. Whole body hyperthermia: biological, and clinical aspects. In Gautherie M, ed. Clinical Thermology. Berlin, Springer, 1992.
12. Robins HI, Kutz M, Wiedemann G, et al. Cytokine induction by 41.8°C whole body hyperthermia.. Cancer Lett 1995, 97, 195-201.
13. Robins HI, Schmitt-Tiggelaar CL, Cohen JD, et al. A new technological approach to radiant heat whole body hyperthermia. Cancer Lett 1994, 79, 137-145.
14. Fields K, Zorsky P, Hiemenz J, Kronish L, Elfenbein G. Ifosfamide, carboplatin and etoposide: a new regimen with a broad spectrum of activity. J Clin Oncol 1994, 12, 544-552.
15. Robins HI. Meeting Report: Systemic Hyperthermia Oncological Working Group. Oncol Int J Cancer Res Treat 1995, 52, 260-263.